Epistemic AI is at the forefront of transforming scientific research through its innovative AI platform, which leverages advanced Knowledge Mapping technology. This technology employs spatial and heuristic reasoning to connect billions of interconnected entities, enabling researchers to uncover hidden relationships among genes, diseases, pathways, and drugs. The platform acts as an AI-enabled research assistant, facilitating various use cases such as basic and translational research, literature reviews, and drug discovery. By providing detailed insights into drug interactions and competitive intelligence, Epistemic AI enhances the efficiency of in silico analysis and supports critical processes like target identification and drug repurposing.

The platform also emphasizes accessibility and inclusivity, aiming to democratize AI tools for life sciences. It streamlines workflows by reducing information overload and offering an intuitive web interface that requires no prior training. Key features include the ability to share Knowledge Maps, analyze subject-specific results, and expand research opportunities through accessible data. By connecting diverse data sources and disciplines, Epistemic AI not only accelerates knowledge discovery but also aims to improve drug development timelines and bring better treatments to market more rapidly.

United States

At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.

We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.

Epistemic AI

Company Details